Abstract

The aim of the present study was to explore the safety and efficacy of radical prostatectomy with a novel Shurui single-port robotic surgical system. A total of 11 patients with prostate cancer were enrolled in this study. Extraperitoneal radical prostatectomy was performed using the Shurui single-port robotic surgical system for all patients. Clinicopathologic data, perioperative data, and short-term surgical outcomes were prospectively collected and analyzed. Of the 11 patients, the median age was 65 years (range, 52-73), and the median body mass index was 22.6 kg/m2 (range, 20.2-26.7). The median operative time was 229 minutes (range, 194-317), and the median console time was 167 minutes (range, 141-265). The median blood loss was 40 mL (range, 10-120), and none of the patients required intraoperative transfusion. There was no conversion to open surgery during the operation, and no assistant ports were added. The surgeons reported a good task load rating with a NASA-TLX score of 25.1±3.3 points. The median postoperative hospital stay time was 7 days (range, 4-15). There were no severe intraoperative or postoperative complications (claviene grade≥3). Postoperative positive surgical margin occurred in 4 (36.4%) patients. No biochemical recurrence occurred within 1 month of surgery. The continence rate was 72.7% (8/11) at 1 month after surgery. The new Shurui single-port robotic surgical system is safe, effective, flexible, and stable for application in radical prostatectomy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call